Form 8-K - Current report:
SEC Accession No. 0001104659-25-066091
Filing Date
2025-07-07
Accepted
2025-07-07 16:12:47
Documents
12
Period of Report
2025-07-01
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519717d1_8k.htm   iXBRL 8-K 26889
  Complete submission text file 0001104659-25-066091.txt   194460

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20250701.xsd EX-101.SCH 3017
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20250701_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20250701_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2519717d1_8k_htm.xml XML 3812
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 251108159
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)